These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 9833862

  • 1. One world, one hope: the cost of providing antiretroviral therapy to all nations.
    Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.
    AIDS; 1998 Nov 12; 12(16):2203-9. PubMed ID: 9833862
    [Abstract] [Full Text] [Related]

  • 2. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M, Chieze F.
    Bull Acad Natl Med; 1990 Nov 12; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [Abstract] [Full Text] [Related]

  • 3. Global estimates of HIV infections and AIDS cases: 1991.
    Chin J.
    AIDS; 1991 Nov 12; 5 Suppl 2():S57-61. PubMed ID: 1845061
    [Abstract] [Full Text] [Related]

  • 4. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
    Wood E, Braitstein P, Montaner JS, Schechter MT, Tyndall MW, O'Shaughnessy MV, Hogg RS.
    Lancet; 2000 Jun 17; 355(9221):2095-100. PubMed ID: 10902622
    [Abstract] [Full Text] [Related]

  • 5. HIV and HTLV-I infections in the Americas: a regional perspective.
    Quinn TC, Zacarias FR, St John RK.
    Medicine (Baltimore); 1989 Jul 17; 68(4):189-209. PubMed ID: 2544782
    [Abstract] [Full Text] [Related]

  • 6. Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.
    Rowley JT, Anderson RM, Ng TW.
    AIDS; 1990 Jan 17; 4(1):47-56. PubMed ID: 2317308
    [Abstract] [Full Text] [Related]

  • 7. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V.
    PLoS Med; 2018 Mar 17; 15(3):e1002514. PubMed ID: 29494593
    [Abstract] [Full Text] [Related]

  • 8. Antiretrovirals for developing world.
    Adler MW.
    Lancet; 1998 Jan 24; 351(9098):232. PubMed ID: 9457091
    [Abstract] [Full Text] [Related]

  • 9. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A, Barker C, Kallarakal A.
    PLoS Med; 2015 Nov 24; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [Abstract] [Full Text] [Related]

  • 10. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
    Panayidou K, Davies MA, Anderegg N, Egger M, IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group.
    J Int AIDS Soc; 2018 Nov 24; 21(11):e25200. PubMed ID: 30614622
    [Abstract] [Full Text] [Related]

  • 11. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S, Antunes OA, Fortunak JM.
    Antiviral Res; 2008 Sep 24; 79(3):143-65. PubMed ID: 18571246
    [Abstract] [Full Text] [Related]

  • 12. Global oral inequalities in HIV infection.
    Challacombe SJ.
    Oral Dis; 2016 Apr 24; 22 Suppl 1():35-41. PubMed ID: 27109270
    [Abstract] [Full Text] [Related]

  • 13. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.
    Am J Trop Med Hyg; 1996 Jul 24; 55(1):1-11. PubMed ID: 8702012
    [Abstract] [Full Text] [Related]

  • 14. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.
    Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S.
    Lancet; 2012 Oct 06; 380(9849):1250-8. PubMed ID: 22828485
    [Abstract] [Full Text] [Related]

  • 15. Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy.
    Anis AH, Hogg RS, Wang XH, Yip B, Palepu A, Montaner JS, O'Shaughnessy MV, Schechter MT.
    Pharmacoeconomics; 1998 Jun 06; 13(6):697-705. PubMed ID: 10179705
    [Abstract] [Full Text] [Related]

  • 16. Provisional country estimates of prevalent adult human immunodeficiency virus infections as of end 1994: a description of the methods.
    Burton AH, Mertens TE.
    Int J Epidemiol; 1998 Feb 06; 27(1):101-7. PubMed ID: 9563702
    [Abstract] [Full Text] [Related]

  • 17. All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS; 2020 Feb 01; 34(2):277-289. PubMed ID: 31876592
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa.
    Marseille E, Kahn JG, Saba J.
    AIDS; 1998 May 28; 12(8):939-48. PubMed ID: 9631148
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.
    Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D, International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.
    J Int AIDS Soc; 2014 May 28; 17(1):19045. PubMed ID: 25516092
    [Abstract] [Full Text] [Related]

  • 20. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA, 2009 Reference Group to the UN on HIV and Injecting Drug Use.
    Lancet; 2010 Mar 20; 375(9719):1014-28. PubMed ID: 20189638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.